Medicare Enrolled

Dr. Shannon Kearney, DO

Allergy Physician · Bethlehem, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3535 HIGH POINT BLVD STE 600, Bethlehem, PA 18017
6108678874
In practice since 2005 (21 years)
NPI: 1306843149 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kearney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kearney? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kearney

Dr. Shannon Kearney is an allergy physician in Bethlehem, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Kearney performed 13,586 Medicare services across 647 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kearney received a total of $34,083 from 45 pharmaceutical and/or device companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kearney is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ Top 12% volume in PA $34,083 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,586
Medicare services
Top 12% in PA for allergy physician
647
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~647 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Omalizumab injection (Xolair) for asthma/allergy 7,740 $30 $113
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
3,224 $3 $13
Skin allergy test
A test where small amounts of potential allergens are injected into the skin to check for allergic reactions.
821 $5 $15
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
582 $8 $40
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
415 $55 $262
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
295 $10 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
235 $62 $140
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
162 $88 $215
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
37 $18 $75
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
34 $112 $275
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
26 $76 $225
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $32 $85
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$34,083
Total received (2018-2024)
Avg $4,869/year across 7 years
Top 12% in PA for allergy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
698
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,841 (52.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,242 (47.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,476
2023
$13,642
2022
$4,116
2021
$2,149
2020
$1,415
2019
$1,199
2018
$1,087

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$6,080
CSL Behring
$896
GENZYME CORPORATION
$830
Takeda Pharmaceuticals U.S.A., Inc.
$654
Amgen Inc.
$334
BioCryst US Sales Co., LLC
$300
GlaxoSmithKline, LLC.
$273
Regeneron Healthcare Solutions, Inc.
$241
Blueprint Medicines Corporation
$237
Regeneron Pharmaceuticals, Inc.
$173
Pharming Healthcare, Inc.
$159
Genentech USA, Inc.
$86
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
Grifols USA, LLC
$47
Octapharma USA, Inc.
$34
Mylan Specialty L.P.
$31
Incyte Corporation
$17
kaleo, Inc.
$15
Lilly USA, LLC
$14
Top 3 companies account for 74.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$18,899
GlaxoSmithKline, LLC.
$2,739
GENZYME CORPORATION
$2,232
CSL Behring
$2,223
Regeneron Healthcare Solutions, Inc.
$1,162
Takeda Pharmaceuticals U.S.A., Inc.
$981
Amgen Inc.
$797
BioCryst US Sales Co., LLC
$705
Boehringer Ingelheim Pharmaceuticals, Inc.
$689
PFIZER INC.
$613
Pharming Healthcare, Inc.
$538
Blueprint Medicines Corporation
$363
Genentech USA, Inc.
$284
Regeneron Pharmaceuticals, Inc.
$195
Optinose US, Inc.
$172
kaleo, Inc.
$133
Octapharma USA, Inc.
$130
Aerin Medical Inc.
$122
Grifols USA, LLC
$106
OptiNose US, Inc.
$96
Novartis Pharmaceuticals Corporation
$95
Inspire Medical Systems, Inc.
$79
Organogenesis Inc.
$73
Neurent Medical Limited
$63
ALK-Abello, Inc
$58
SANOFI-AVENTIS U.S. LLC
$46
Bio Products Laboratory USA, Inc.
$45
Acclarent, Inc
$38
BioFire Diagnostics, LLC
$36
AIMMUNE THERAPEUTICS, INC.
$34
Mylan Specialty L.P.
$31
LEO Pharma Inc.
$30
Incyte Corporation
$29
Covis Pharma GmBH
$28
Teva Pharmaceuticals USA, Inc.
$27
Intersect ENT, Inc.
$27
ABBVIE INC.
$24
Stryker Corporation
$23
Aimmune Therapeutics, Inc.
$21
Phadia US Inc.
$19
Cook Medical LLC
$19
AYTU BioPharma, Inc.
$18
Aytu BioPharma, Inc.
$15
Horizon Therapeutics plc
$15
Lilly USA, LLC
$14
Top 3 companies account for 70.0% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · ALVESCO · AUVI-Q · AYVAKIT · Acclarent Aera · AirDuo Digihaler · BREO · BREZTRI · BREZTRI AEROSPHERE · BioFire FilmArray · CUTAQUIG · CUVITRU · Cook Medical Biodesign · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENTELLUS - XPRESS ENT DILATION SYSTEM · EOHILIA · EUCRISA · FARXIGA · FASENRA · Gammaplex · HYQVIA · Haegarda · Hizentra · INSPIRE · ImmunoCAP · JOENJA · Karbinal · Kcentra · NEUROMARK Device · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · PROPEL · ProAir Digihaler · Puraply · RINVOQ · RUCONEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · Vivaer RF Stylus · XOLAIR · Xembify · Xhance · Xolair · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (52%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an allergy physician in Bethlehem?
Compare allergy physicians in the Bethlehem area by procedure volume, costs, and industry payment transparency.
Browse allergy physicians nearby

Geographic Context

Allergy physicians within 10 mi
4
Per 100K population
1.3
County median income
$86,687
Nearest hospital
ST LUKES HOSPITAL BETHLEHEM
5.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kearney is a mixed practice specialist, with above-average Medicare volume (top 12% in PA), with low-engagement industry engagement in the top 12% of PA peers, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kearney experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Kearney performed 7,740 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kearney receive payments from pharmaceutical companies?
Yes. Dr. Kearney received a total of $34,083 from 45 companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kearney's costs compare to other allergy physicians in Bethlehem?
Dr. Kearney's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kearney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →